Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.

Comparing Gross Profit Trends in Healthcare Giants

__timestampMiMedx Group, Inc.United Therapeutics Corporation
Wednesday, January 1, 20141055580001162636000
Thursday, January 1, 20151670940001396725000
Friday, January 1, 20162126080001526100000
Sunday, January 1, 20172859200001619600000
Monday, January 1, 20183227250001429100000
Tuesday, January 1, 20192561740001331200000
Wednesday, January 1, 20202089040001375200000
Friday, January 1, 20212153320001563000000
Saturday, January 1, 20222195250001789600000
Sunday, January 1, 20232668430002070000000
Loading chart...

In pursuit of knowledge

Gross Profit Trends: A Tale of Two Companies

In the competitive landscape of the healthcare sector, United Therapeutics Corporation and MiMedx Group, Inc. have shown distinct trajectories in their gross profit trends over the past decade. From 2014 to 2023, United Therapeutics consistently outperformed MiMedx, with its gross profit peaking at approximately $2.07 billion in 2023, marking an impressive 78% increase from 2014. In contrast, MiMedx Group's gross profit grew by 153% over the same period, reaching around $267 million in 2023.

A Decade of Growth and Challenges

While United Therapeutics maintained a steady growth, MiMedx experienced fluctuations, notably a dip in 2019. This divergence highlights the varying strategies and market conditions faced by these companies. As the healthcare industry evolves, these trends offer valuable insights into the financial health and strategic direction of these key players.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025